Accendra Health, Inc.
- ACH
- NYSE
- Medical - Distribution
- Medical Products
- Healthcare Services
- Direct-to-Patient
$0.22
Today −6.30%Quote Oct 19, 2026, 08:01 PM UTC
−77.18%over the last month
Max drawdown −77.2%From 1-month high −77.2%3 months −92.9%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About Accendra Health
Accendra Health, Inc., along with its subsidiaries, operates globally as a comprehensive provider of healthcare solutions. The organization is structured into two primary operational divisions: Products & Healthcare Services and Patient Direct.
Where the money comes from
Q2 2026 revenue $613.2M
- Diabetes Product$198.8M32.4%
- Product and Service, Other$47.7M7.8%
- Wound Care$40.2M6.6%
- Urology$31.3M5.1%
- Other / not reported$295.2M48.1%
Sector
Healthcare
Industry
Medical - Distribution
Exchange
NYSE
Employees
6,500
Founded
1882
Market value
$16.9M
Quote Oct 19
Analyst target
$1.50
+581.2% from here
Resistance
$0.28
26.3% above price
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about ACHPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free